Molecular Science Corp. (“MSC” or the “Company”). is pleased to announce Molecular Science Labs Corp., a wholly owned subsidiary of MSC, has received a Dealer’s License pursuant to the provisions of the Controlled Drugs and Substances Act and its Regulations from Health Canada.

Licensed activities will occur in MSC’s state of the art lab facility located in Scarborough, Ontario, where cannabis samples can be received for the purpose of analytical testing.  MSC’s lab services will include multiple analyses including pesticides, heavy metals, and potency in cannabis flower, cannabis oil extract and hemp.  This facility will implement processes in line with pharmaceutical industry best practices for analytical testing using high end LC-MS/MS, GC-MS/MS, ICP-MS and advanced automation systems.

“Achievement of this Dealer’s License allows MSC to continue on the path to providing the Canadian LPs with precise, efficient cannabis testing and product analysis in an effort to improve consumer safety as well as cultivation and extraction processes in line with Health Canada regulations,” said Dr. Mauro Aiello, VP of Laboratory Operations and Product Development. “MSC is committed to improving the turn-around time, quality and reliability of analytical testing for the Cannabis industry through innovations in science, technology and efficient Quality Assurance processes. MSC’s highly skilled team is implementing advanced methodologies and systems to achieve these goals.